Healthcare provider profile · identity verified

Mark A Richetto, MD

Internal Medicine · WAUSAU, WI · NPI 1689769960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	922	269
Amlodipine Besylate	Amlodipine Besylate	545	153
Lisinopril	Lisinopril	514	160
Metoprolol Succinate	Metoprolol Succinate	387	113
Levothyroxine Sodium	Levothyroxine Sodium	305	87
Hydrochlorothiazide	Hydrochlorothiazide	304	91
Omeprazole	Omeprazole	302	95
Losartan Potassium	Losartan Potassium	291	83
Eliquis	Apixaban	279	58
Tamsulosin Hcl	Tamsulosin Hcl	268	85
Metformin Hcl	Metformin Hcl	245	69
Rosuvastatin Calcium	Rosuvastatin Calcium	169	52
Simvastatin	Simvastatin	145	47
Metoprolol Tartrate	Metoprolol Tartrate	142	49
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	137	42
Gabapentin	Gabapentin	135	44
Allopurinol	Allopurinol	134	37
Pantoprazole Sodium	Pantoprazole Sodium	132	41
Furosemide	Furosemide	131	44
Warfarin Sodium	Warfarin Sodium	115	32
Albuterol Sulfate Hfa	Albuterol Sulfate	108	38
Alendronate Sodium	Alendronate Sodium	106	34
Glipizide	Glipizide	104	27
Pravastatin Sodium	Pravastatin Sodium	92	29
Clopidogrel	Clopidogrel Bisulfate	90	28
Atenolol	Atenolol	89	27
Potassium Chloride	Potassium Chloride	89	31
Jardiance	Empagliflozin	79	22
Trulicity	Dulaglutide	79	12
Tramadol Hcl	Tramadol Hcl	71	20
Finasteride	Finasteride	70	23
Sertraline Hcl	Sertraline Hcl	70	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	68	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	67	22
Prednisone	Prednisone	67	32
Trazodone Hcl	Trazodone Hcl	63	21
Famotidine	Famotidine	60	24
Amoxicillin	Amoxicillin	58	31
Enalapril Maleate	Enalapril Maleate	58	16
Irbesartan	Irbesartan	58	19
Carvedilol	Carvedilol	56	16
Chlorthalidone	Chlorthalidone	55	15
Escitalopram Oxalate	Escitalopram Oxalate	55	16
Metformin Hcl Er	Metformin Hcl	55	22
Spironolactone	Spironolactone	55	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	13
Fluticasone Propionate	Fluticasone Propionate	48	18
Alprazolam	Alprazolam	43	13
Ezetimibe	Ezetimibe	42	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	14
Arexvy	Rsvpref3 Antigen/As01e/Pf	37	36
Citalopram Hbr	Citalopram Hydrobromide	37	11
Lovastatin	Lovastatin	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Valsartan	Valsartan	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	14
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	29	21
Xarelto	Rivaroxaban	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	11
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Ozempic	Semaglutide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Estradiol	Estradiol	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	21
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Colchicine	Colchicine	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	15	15
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Nystatin	Nystatin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Levoxyl	Levothyroxine Sodium	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error